Literature DB >> 22864060

Enhanced expression of organic anion transporting polypeptides (OATPs) in androgen receptor-positive prostate cancer cells: possible role of OATP1A2 in adaptive cell growth under androgen-depleted conditions.

Hiroshi Arakawa1, Takeo Nakanishi, Chihiro Yanagihara, Tomohiro Nishimoto, Tomohiko Wakayama, Atsushi Mizokami, Mikio Namiki, Keiichi Kawai, Ikumi Tamai.   

Abstract

The biological mechanisms underlying castration resistance of prostate cancer are not fully understood. In the present study, we examined the role of organic anion transporting polypeptides (OATPs) as importers of dehydroepiandrosterone sulfate (DHEAS) into cells to support growth under androgen-depleted conditions. Cell growth and mRNA expression of OATP genes were studied in human prostate cancer LNCaP and 22Rv1 cells under androgen-depleted conditions. The stimulatory effect of DHEAS on cell growth was investigated in LNCaP cells in which OATP1A2 had been silenced. Growth of both cell lines was stimulated by DHEAS and the effect was attenuated by STX64, an inhibitor of steroid sulfatase which can covert DHEAS to DHEA. OATP1A2 mRNA expression was increased most prominently among various genes tested in LNCaP cells grown in androgen-depleted medium. Similar results were obtained with 22Rv1 cells. Furthermore, the characteristics of [(3)H]DHEAS uptake by LNCaP cells were consistent with those of OATP-mediated transport. Knockdown of OATP1A2 in LNCaP cells resulted in loss of the DHEAS sensitivity of cell growth. Our results suggest that enhanced OATP1A2 expression is associated with adaptive cell growth of prostate cancer cells under androgen-depleted conditions. Thus, OATP1A2 may be a pharmacological target for prostate cancer treatment.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22864060     DOI: 10.1016/j.bcp.2012.07.026

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  29 in total

Review 1.  Intracrinology-revisited and prostate cancer.

Authors:  Trevor M Penning; Andrea J Detlefsen
Journal:  J Steroid Biochem Mol Biol       Date:  2019-10-12       Impact factor: 4.292

Review 2.  Dehydroepiandrosterone (DHEA)-SO4 Depot and Castration-Resistant Prostate Cancer.

Authors:  Trevor M Penning
Journal:  Vitam Horm       Date:  2018-02-24       Impact factor: 3.421

Review 3.  Mechanisms of drug resistance that target the androgen axis in castration resistant prostate cancer (CRPC).

Authors:  Trevor M Penning
Journal:  J Steroid Biochem Mol Biol       Date:  2015-05-29       Impact factor: 4.292

4.  Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  J Med Chem       Date:  2015-06-12       Impact factor: 7.446

Review 5.  Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression.

Authors:  Eunpi Cho; R Bruce Montgomery; Elahe A Mostaghel
Journal:  Endocrinology       Date:  2014-08-22       Impact factor: 4.736

6.  Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance.

Authors:  Hannah H Lee; Brenda F Leake; Richard B Kim; Richard H Ho
Journal:  Mol Pharmacol       Date:  2016-10-24       Impact factor: 4.436

7.  Loss of exogenous androgen dependence by prostate tumor cells is associated with elevated glucuronidation potential.

Authors:  Brenna M Zimmer; Michelle E Howell; Qin Wei; Linlin Ma; Trevor Romsdahl; Eileen G Loughman; Jonathan E Markham; Javier Seravalli; Joseph J Barycki; Melanie A Simpson
Journal:  Horm Cancer       Date:  2016-06-15       Impact factor: 3.869

Review 8.  Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy.

Authors:  Nilay Thakkar; A Craig Lockhart; Wooin Lee
Journal:  AAPS J       Date:  2015-03-04       Impact factor: 4.009

9.  Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer.

Authors:  Elahe A Mostaghel; Eunpi Cho; Ailin Zhang; Mohammad Alyamani; Arja Kaipainen; Sean Green; Brett T Marck; Nima Sharifi; Jonathan L Wright; Roman Gulati; Lawrence D True; Massimo Loda; Alvin M Matsumoto; Daniel Tamae; Trevor N Penning; Steven P Balk; Phillip W Kantoff; Peter S Nelson; Mary-Ellen Taplin; R Bruce Montgomery
Journal:  Clin Cancer Res       Date:  2017-04-07       Impact factor: 12.531

10.  Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters.

Authors:  Hiroyuki Okudaira; Shuntaro Oka; Masahiro Ono; Takeo Nakanishi; David M Schuster; Masato Kobayashi; Mark M Goodman; Ikumi Tamai; Keiichi Kawai; Yoshifumi Shirakami
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.